# Inhibrx Biosciences, Inc.: Form 8-K, filed May 24, 2024

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: 8-K
- Filed: 2024-05-24
- Accepted by EDGAR: May 24, 2024, 20:21 ET
- Period: 2024-05-24
- Accession: 0001104659-24-065140
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000110465924065140/tm243190d17_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000110465924065140/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000110465924065140/tm243190d17_8k.htm

Filed May 24, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-065140. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.